Concourse Financial Group Securities, Inc. Procept Bio Robotics Corp Transaction History

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share
Q1 2025 May 14, 2025	BUY	$56.03 - $88.57 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$67.27 - $99.45 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$56.31 - $84.99 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$45.73 - $69.19 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$40.38 - $50.75 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$24.89 - $43.41 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$30.02 - $38.81 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$30.02 - $38.81 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$26.7 - $37.02 $0 - $0
Q1 2023 May 15, 2023	BUY	$26.64 - $39.74 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$38.78 - $46.78 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$30.9 - $50.65 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$29.23 - $44.45 $0 - $0
Q1 2022 May 09, 2022	BUY	$16.89 - $35.74 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$24.6 - $46.29 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$35.91 - $41.94 $0 - $0

Others Institutions Holding PRCT

# of Institutions

301

Shares Held

41.9M

Call Options Held

293K

Put Options Held

141K

Vanguard Group Inc Valley Forge, PA

5.13M
Shares

$334 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.49M
Shares

$227 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

2.14M
Shares

$139 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

1.42M
Shares

$92.1 Million
0.05% of portfolio
State Street Corp Boston, MA

1.19M
Shares

$77.2 Million
0.0% of portfolio

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $2.9B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account